Keep up with the Challenge of PPCP Detection and Analysis
Pharmaceuticals and personal care products (PPCPs) & hormones enter our water supplies through human excretion, domestic and industrial disposal into wastewater treatment plants, agricultural runoff and animal feed lot operations. One of the negatives effects that active hormones found on excrement can have on both humans and wildlife is endocrine disruption, which may occur at extremely low ng/L levels. PPCPs are quite resilient and are difficult to remove through conventional water treatment processes, resulting in persistence in the environment and potential accumulation over time. The negative effect of sub-chronic, low-level yet long-term exposure of a mixture of these compounds through water is currently unknown. Due to the level of uncertainty that PPCPs may cause over time, many countries continue to monitor PPCPs and hormones in their water supplies to establish baseline levels that can be used until sufficient toxicological data about the impact of PPCPS and hormones is collected.
Agilent offers complete solutions including online and offline solid phase extraction techniques, and LC-MS and GC-MS systems to analyze PPCPs and hormones at sub ng/L levels in the environment. Agilent’s unique flexcube online SPE solution allows automated and rapid analysis of PPCPs and hormones in drinking water at low ng/L levels with just a few mL of sample. Robust offline solid phase extraction cartridges and Enhanced Matrix Removal-Lipid (EMR-L) solutions are ideal for extraction of these compounds from water, soil, sludge and biota. The 6400 series triple quadrupole LC/MS system and Ultivo provide sensitive, robust and reliable detectors for easy analysis of these compounds in environmental samples.